SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on Immunotherapy

    Archives: Immunotherapy

    Novel Anti-tumor Vaccine Developed  Oct 4, 2008
    3, 2008) A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice, according to new research published in the October edition of the research journal Cancer Immunology, Immunotherapy ... In recent years, the concept of vaccine immunotherapy for. (Science Daily)

    Rapid Fire-Ant Sting Desensitization OK in Kids  Oct 3, 2008
    The one-day protocol, "which can safely reach a protective dose of immunotherapy in a short amount of time, would be a therapeutic option for any-age patient with imported fire ant allergy.". Tankersley, from Lackland Air Force Base, San Antonio, Texas and colleagues describe three children 36 months or younger who completed a one-day rapid immunotherapy protocol with imported fire ant whole-body extract ... After the rapid desensitization, the children went on to monthly maintenance... (MEDLINEplus)

    'Allergic Girl' teaches allergy-free dining  Sep 18, 2008
    The largest group of studies on the subject are in progress, including immunotherapy for people with peanut and milk allergies, she said. The majority of food allergy cases -- about 80 percent -- are "cyclic," with mild symptoms that resemble those of pollen or dust allergies: sneezing, itchy eyes, and nasal congestion, said Dr. Alpen Patel, assistant professor of otolaryngology at Emory University. (CNN -- Health)

    Illness forces band director to retire  Sep 14, 2008
    It is resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy. Targeted cancer therapies such as sunitinib have improved the outlook for RCC, although they have not yet demonstrated improved survival. (Atmore Advance, AL)

    Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain  Sep 11, 2008
    As noted above, DCVax(R)-Brain is a personalized immunotherapy designed to stimulate a patient's own immune system to fight cancer ... About Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, on a cost-effective basis. (PR Newswire)

    Scientists Identify Genetic Link That May Neutralize HIV  Sep 8, 2008
    "We now have a host factor needed for the production of neutralizing antibodies that HIV targets and destroys," said Gladstone scientist Mario Santiago, PhD. "This offers a fresh perspective on how to strengthen this arm of the immune response against HIV, with direct implications for immunotherapy and vaccine development.". The scientists conducted a series of genetic experiments by mating mice with different Rfv3 and Apobec3 profiles. (Science Daily)

    Cancer Immunotherapy  Sep 4, 2008
    To the Editor: In his review of cancer immunology, Finn (June 19 issue)1 states that the results of immunotherapy involving intravenous administration of tumor-specific autologous T cells (adoptive cell therapy) are "marginal," whereas the results of trials of cancer vaccines are "encouraging." We do not believe this conclusion accurately reflects the state of the field. In 1994, we reported a 34% objective response rate among patients with metastatic melanoma who were treated with adoptive cell... (New England Journal of Medicine)

    Bone Marrow Transplantation  Aug 29, 2008
    Written by acknowledged world experts, it includes a comparison of different stem cell sources, and looks at reduced intensity allografting, cellular immunotherapy and post transplant relapse. Guest edited by Mitchell S. Cairo and Helen Heslop, this special issue is the first of its kind. (Nature News Service)

    Cancer Gene Therapy  Aug 29, 2008
    It publishes original laboratory and clinical research papers, case reports and review articles on topics including RNAi approaches, drug resistance, hematopoietic gene transfer, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors,translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA ymes), apoptosis; mechanisms and therapies , vaccine development, immunology and... (Nature News Service)

    Cell Genesys shares recover slightly, up 30%  Aug 29, 2008
    Vital-2 was the second of two Phase 3 clinical trials of Gvax immunotherapy for prostate cancer. Reader Comments. (San Jose Business Journal, CA)

    Alternative Vaccine Strategy Shows Promise In Prostate Cancer Patients  Aug 26, 2008
    In recent years, the concept of vaccine immunotherapy for. (July 8, 2002) A new vaccination strategy targeting telomerase, one of the enzymes responsible for making cancer cells immortal, has been tested by Professor Trond Buanes on patients with pancreatic cancer at. (Science Daily)

    Bioniche Animal Health Immunotherapy Now Listed as "Organic" for Use in Cattle  Aug 25, 2008
    QUICK SEARCH BY ORGANIZATION. FREE SUBSCRIPTION SERVICES. (Canada Newswire)

    Cancer and immunotherapy Q and A  Aug 16, 2008
    What is immunotherapy ... Gradually, however, tumour cells get selected by a Darwinian process of survival of the fittest, so that they begin to shrug off T cells and immunotherapy becomes less effective ... Has immunotherapy been used before. (Telegraph.co.uk)

    New Lymphoma Drug Shows Promise  Aug 16, 2008
    THURSDAY, Aug. 14 (HealthDay News) -- Preliminary results from an early trial of a new immunotherapy suggests doctors may soon have another weapon for the treatment of non-Hodgkin lymphoma. A team of German scientists and clinicians led by Patrick Baeuerle, chief scientific officer at Micromet AG, a Munich-based biopharmaceutical company, demonstrated partial or complete tumor regression in 11 of 38 human patients given low doses of blinatumomab, a protein that tethers tumor-killing T-cells to... (MEDLINEplus)

    Personalized immunotherapy to fight HIV/AIDS  Aug 16, 2008
    Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Skaly from the Universit de Montral, have overcome this difficulty by designing a personalized immunotherapy for HIV-infected patients ... "Our approach is unique in the world: no one else has yet developed customized immunotherapy using the virus from individual patients," said Dr. Routy ... This immunotherapy is based on the properties of dendritic... (EurekAlert!)

    Dendreon begins more testing of Provenge prostate cancer drug  Aug 15, 2008
    The other is a 40-subject, single-center trial called its neoadjuvant active cellular immunotherapy trial. Dendreon said prostate cancer is the most common nonskin cancer in the U.S., affecting more than 1 million men in the country; nearly 29,000 men will die from the disease this year. (Puget Sound Business Journal, WA)

    Roche in $43.7bln bid for last Genentech shares  Aug 15, 2008
    Josef M. Issels, M.D., developed a Comprehensive Immunotherapy for cancer and achieved complete remission of "incurable cancers" without further recurrence for up to four decades. www. (Yahoo News -- Pharmaceutical Industry News)

    Scientists Use Old Enemy To K.O. Cancer  Aug 14, 2008
    13, 2008) Chemists are pulling cancer onto a sucker punch by getting infected cells to drop their guard according to new research. They are using the metal ruthenium as a catalyst to a cancer-busting reaction which calls up an old cellular enemy oxidants as an ally. (Science Daily)

    Allergies May Be Worse On Warming Earth  Aug 14, 2008
    Allergy shots and immunotherapy are successful treatments for treating ragweed allergy patients, he said. AAAI also suggests that patients protect themselves from direct exposure to the ragweed pollen by keeping windows closed and staying indoors when pollen counts are highest. (Click2Houston, TX)

    Multi-tasking Molecule Holds Key To Allergic Reactions  Aug 9, 2008
    8, 2008) As the summer approaches most of us rejoice, reach for the sunscreen and head outdoors. But an ever-growing number of people reach for tissue instead as pollen leaves eyes watering, noses running and spirits dwindling. (Science Daily)

    Enrollment of Breast and Ovarian Cancer Patients Commenced for Combination Therapy Trial to Include Generex Biotechnology's Novel Immunotherapeutic Vaccine  Aug 7, 2008
    Both pre-clinical and clinical studies have shown the importance of activation of this cell type for successful cancer immunotherapy. The trial is being conducted as part of a collaboration between Antigen Express, Dr. George Peoples at the Brooke Army Medical Center and the Mary Crowley Cancer Center, which is funding the trial. (Primezone Releases)

    Immunotherapy Boosts Treatment of Kids' High-Risk Sarcomas  Aug 4, 2008
    MONDAY, Aug. 4 (HealthDay News) -- Immunotherapy shows promise in treating children with high-risk sarcomas, according to a U.S. National Institute of Health pilot study ... The study of 52 patients with recurrent and/or metastatic Ewing's sarcoma or alveolar rhabdomyosarcoma also found that those who received immunotherapy had better-than-normal survival ... Patients who received immunotherapy had a 43 percent five-year overall survival, compared to 31 percent for those who didn't receive... (Health-Finder)

    Immunotherapy in high-risk pediatric sarcomas shows promising response  Aug 1, 2008
    PHILADELPHIA Based on a pilot study in children with sarcoma, researchers at the National Institutes of Health (NIH) believe that immunotherapy could prove beneficial in treating high-risk forms of this cancer ... The 22 enrolled patients who did not receive immunotherapy had a 31 percent five-year overall survival, compared to 43 percent five-year survival in 30 patients who ultimately received the novel immunotherapy ... "We need new therapies. While outcomes overall for these tumors have... (EurekAlert!)

    NYU Langone Medical Center's tip sheet to the International Conference on Alzheimer's Disease 2008  Jul 26, 2008
    Tau Immunotherapy Prevents Cognitive Decline in an Alzheimer's Mouse Model Einar M. Sigurdsson, PhD, Assistant Professor of Psychiatry and Pathology, NYU Langone Medical Center EMBARGOED FOR RELEASE UNTIL WEDNESDAY, JULY 30, 2008 at 3:45 p.m. CT ... Tests confirmed that the immunotherapy helped preserve cognition as well as reduced tau protein tangles in the brain ... The findings support the possibility of an immunotherapy that treats Alzheimer's disease by directly targeting toxic forms of the... (EurekAlert!)

    Conductor James Levine had malignant kidney growth  Jul 24, 2008
    Further surgery, treatment with targeted therapies or immunotherapy could be considered in cases of cancers that recur after initial surgery, the American Cancer Society says on its Web site ... Treatments such as targeted therapy, chemotherapy, radiation therapy or immunotherapy are usually not recommended after surgery for early stage kidney cancer except as a part of a clinical trial, according to the American Cancer Society. (Alexander City Outlook, AL)

    Achilles Heel Of HIV Pinpointed?  Jul 16, 2008
    Pathologists Believe They Have Pinpointed Achilles Heel Of HIV. Pathologists Believe They Have Pinpointed Achilles Heel Of HIV. (Science Daily)

    Researchers Locate And Image Prostate Cancer As It Spreads To Lymph Nodes  Jul 15, 2008
    (May 23, 2001) Researchers at UCLA s Jonsson Cancer Center have shown for the first time that immunotherapy delivered via gene therapy may prove to be a potent weapon in the fight against locally advanced. . (Science Daily)

    Byrd Institute researchers get Alzheimer's grants  Jul 13, 2008
    Chuanhai Cao was awarded $50,000 by the Parkinson's Research Foundation to continue developing his innovative approach to immunotherapy. Jaya Padmanabhan received a three-year $240,000 grant from the Alzheimer's Association to continue her work on the regulatory functions of inflammatory proteins in Alzheimer's disease. (Tampa Bay Business Journal, FL)

    Kidney Cancer Vaccine Shows No Boost in Survival  Jul 5, 2008
    The field of cancer immunotherapy is weakened when some researchers and vaccine companies are reluctant to accept the results of randomized clinical trials, Yang said. "Commercially driven efforts that spin or obfuscate the conclusions of such a trial should be vigorously resisted because such efforts severely erode its value," he concluded. (MEDLINEplus)

    Silencing Of Molecular 'Conversation' May Help Curb Severe Allergies  Jul 1, 2008
    12, 2004) Children who have severe allergic reactions when stung by bees, wasps and other insects should receive venom immunotherapy, or allergy shots, to reduce the chance of future life-threatening reactions. (Oct. (Science Daily)

    Alzheimer's Drug Shows Early Promise  Jul 1, 2008
    "This is the first study of adequate size and duration that suggests the immunotherapy beta-amyloid model works," said Dr. Anton Porsteinsson, an associate professor of psychiatry at the University of Rochester School of Medicine who was one of the investigators for the study. "Immunotherapy is a huge front in the development of treatments." ... Immunotherapy, an emerging frontier for a variety of different diseases, involves stimulating the body's own immune system to fight various conditions,... (MEDLINEplus)

    Washington Univ. awards $150,000 in Bear Cub Fund grants  Jun 26, 2008
    Linette will use his grant to make adoptive T cell immunotherapy a reality for patients with infectious diseases and cancer. The Bear Cub grant will help Moran's developed microelectrode to be fabricated, implanted in the sciatic nerves of rats and evaluated. (St. Louis Business Journal, MO)

    Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies  Jun 26, 2008
    Antigen Express has previously identified a novel peptide vaccine for melanoma and published its findings in an article titled, ``Enhanced CD4+ T-Cell Response in DR4-Transgenic Mice to a Hybrid Peptide Linking the Ii-Key Segment of the Invariant Chain to the Melanoma gp100(48-58) MHC Class II Epitope,'' in the Journal of Immunotherapy, volume 28, pages 352-358, 2005. We are excited to begin the process of moving this into the clinic with Dr. Markovic,'' said Dr. Eric von Hofe, President of... (Primezone Releases)

    Man's Melanoma Thwarted by Immune Fix  Jun 20, 2008
    "There are many other immunotherapy treatments that we're not doing, that other people are doing, that probably deserve more attention." ... T-cell therapy is "promising," but there are "many other examples of effective cancer immunotherapy," writes editorialist Louis M. Weiner, MD, director of Georgetown University's Lombardi Comprehensive Cancer Center. (WebMD)

    Terminal Skin Cancer Patient Saved By Treatment Co-Authored By Seattle Doctor  Jun 20, 2008
    But Dr. Darrell Rigel, a dermatology researcher at the New York University Cancer Institute, says immunotherapy has become the most promising approach to late-stage skin cancers. Two years after his remarkable recovery, the patient fell out of contact with researchers and scientists do not know his current condition. (KIRO TV, WA)

    Cancer beaten by dose of own cells  Jun 20, 2008
    The director of the Sydney Melanoma Unit, John Thompson, said a positive response in one patient from the immunotherapy was encouraging. "But ... it will require a lot more work to see if it is reproducible.". (Sydney Morning Herald -- Australia)

    Small success with immunotherapy in skin cancer study  Jun 20, 2008
    "Immunotherapy has become the most promising approach" to late-stage, death-sentence skin cancers, said Dr. Darrell Rigel, a clinical professor of dermatology at the Medical Center in who had no role in the research. Still, the immune-priming experiments have yet to yield a consistent therapy. (Newsday)

    Experimental Therapy Beats Back One Patient's Melanoma  Jun 20, 2008
    Immunotherapy, which engages a patient's own immune system to fight cancer, is an emerging art and science ... And therein lies a major problem with immunotherapy as it exists now ... "Obviously there's a lot of promise for immunotherapy of this kind but I think that we're several years away from making this any kind of standard therapy," Yee said. (MEDLINEplus)

    Allergy expert has advice for flood victims  Jun 20, 2008
    If a doctor confirms that health symptoms stem from a reaction to mold, medical treatments are effective: those can be pharmacotherapy which may include antihistamines or steroids, given intranasally or orally or if necessary, immunotherapy, often called allergy shots, which allow your immune system to build up a tolerance to the allergen. But Wedner emphasizes that the source of the reaction, the mold itself, also has to be removed. (EurekAlert!)

    Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation  Jun 19, 2008
    Using a patient's own immune system to combat cancer, called immunotherapy, is a growing area of research that aims to develop less-toxic cancer treatments than standard chemotherapy and radiation. The patient in the journal report was one of nine patients with metastatic melanoma who were being treated in a recently completed clinical trial to test dose-escalation of autologous CD4+ T cells. (PR Newswire)

    New regimen saves man with deadly melanoma  Jun 19, 2008
    "Immunotherapy has become the most promising approach" to late-stage, death-sentence skin cancers, said Dr. Darrell Rigel, a dermatology researcher at the New York University Cancer Institute in New York who had no role in the research. advertisement. (MSNBC -- Health)

    HOPE FOR SKIN CANCER CURE...  Jun 19, 2008
    Using a patient's own immune system to combat cancer, called immunotherapy, is a growing area of research that aims to develop less-toxic cancer treatments than standard chemotherapy and radiation. Some 160,000 cases of melanoma are diagnosed around the world every year, particularly affecting white men living in very sunny regions. (The Drudge Report)

    Cancer Immunotherapy — The Endgame Begins  Jun 19, 2008
    NEJM -- Cancer Immunotherapy -- The Endgame Begins ... Cancer Immunotherapy The Endgame Begins ... In 1987, an editorial accompanying a report on the use of high-dose interleukin-2 therapy for cancer asked whether the field of immunotherapy was at "the beginning of the end" or "the end of the beginning."1 In retrospect, I would say it was at the "beginning of the beginning." Have we made progress since then. (New England Journal of Medicine)

    Cancer Immunology  Jun 19, 2008
    This review deals with important new concepts in antitumor immunity and their application to immunotherapy ... Immunotherapy with Antibodies and T Cells. (New England Journal of Medicine)

    Allergies: Specific Immunotherapy Works For Many People, Research Suggests  Jun 17, 2008
    " The Institute has reviewed the latest independent analyses of allergy research to find out which treatments or prevention measures could really work. Allergen immunotherapy can done by injections or sublingual ("under the tongue") drops, tablets or sprays. Both injections and sublingual treatments work. A report* shows that more than a dozen of these immunotherapy extracts are now amongst the 3,000 most prescribed medicines in Germany. According to Professor Sawicki, "Sublingual therapy in... (Science Daily)

    Are you allergic to Atlanta?  Jun 17, 2008
    Immunotherapy (allergy shots) treats allergic asthma conditions. Injection therapy blocks the allergic antibody (Xolair). (Atlanta Journal-Constitution)

    Ancient Antibody Molecule Offers Clues To How Humans Evolved Allergies  Jun 15, 2008
    14, 2008) Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered how evolution may have lumbered humans with allergy problems. The team from the Randall Division of Cell & Molecular Biophysics, King's College London are working on a molecule vital to a chicken's immune system which represents the evolutionary ancestor of the human antibodies that cause allergic reactions. (Science Daily)

    Plainsboro resident tapped for prominent post  Jun 12, 2008
    Lattime currently chairs the National Cancer Institute's Cancer Immunopathology and Immunotherapy grant review panel. He has written more than 100 scientific publications and is the editor of "Gene Therapy of Cancer.". (NJ.com -- Times)

    New Model Predicts Whether Patients Will Be Free Of Renal Cancer 12 Years After Initial Treatment  Jun 8, 2008
    Kidney cancer is notoriously resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy. Recently developed molecular therapies have also shown great promise for treatment. (Science Daily)

    Galiximab in combination with rituximab in patients with previously untreated follicular lymphoma  Jun 8, 2008
    Thirteen percent of patients reported a grade 3 adverse event; no grade 4 toxicities were associated with this combination immunotherapy regimen. Galiximab is an anti-CD80 monoclonal antibody that has been studied as a single-agent in previously treated FL and in combination with rituximab against relapsed FL. The CD80 molecule is found on the surface of activated macrophages, dendritic cells and cells from various subtypes of NHL. Galiximab's potential mechanisms of action include... (EurekAlert!)

    Cancer Teen Turning 18  Jun 7, 2008
    Smith has been treating Cherrix with concentrated doses of radiation, plus immunotherapy - medicines and supplements, including a form of Vitamin C, that he says bolster the immune system. Smith initially treated a baseball-sized tumor on Cherrix's neck. (WTVR.com, VA)

    All eyes on S.F. diabetes conference  Jun 6, 2008
    (06-05) 19:59 PDT -- More than 13,000 diabetes experts will converge on San Francisco today for one of the most anticipated diabetes conferences in the world, a five-day event that will cover a broad spectrum of topics both scientific and social - from the emerging field of immunotherapy to whether kids should be allowed to give themselves insulin shots in school ... Immunotherapy is an especially compelling area of research for doctors who develop new treatments for Type 1 but find themselves... (San Francisco Chronicle)

    New melanoma drugs why do so few benefit?  Jun 5, 2008
    Gajewski pointed to efforts by GlaxoSmithKline, which is using genetic profiling as a means of predicting who will benefit most from the companys experimental immunotherapy drug MAGE-A3 ASCI for advanced melanoma. Researchers this week said a study of biopsies of melanoma tumors taken from people before treatment uncovered a common genetic signature in those who later responded to MAGE-A3 ASCI.. (MSNBC -- Health)

    Drug Found To Stimulate Immune System In Patients With Prostate Cancer  Jun 4, 2008
    (May 23, 2001) Researchers at UCLA s Jonsson Cancer Center have shown for the first time that immunotherapy delivered via gene therapy may prove to be a potent weapon in the fight against locally advanced. (Jun. (Science Daily)

    Vaccine doubles survival of deadly cancer  Jun 3, 2008
    "This is probably one of the biggest, if not the biggest, immunotherapy deals that has been made," Dr. Sampson said. "If this works, I think there will be more investment in vaccines.". (Globe and Mail)

    Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients  Jun 2, 2008
    CHICAGO, June 1 /PRNewswire/ -- Researchers at the Barbara Ann Karmanos Cancer Institute in Detroit today presented findings that show immunotherapy with armed targeted T cells may improve the overall survival of women with metastatic breast cancer. (Logo: O ) Abstract 3034, Phase I immunotherapy in women with metastatic breast cancer with activated T cells targeted with anti-CD-3 x anti-Her2/neu bispecific antibody, was given at the American Society of Clinical Oncology Annual Meeting in... (PR Newswire)

    Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO  Jun 2, 2008
    g., vandetanib, sorafenib, motesanib), chemotherapeutics, immunotherapy, radioactive iodine, and radiotherapy. "Patients with medullary thyroid cancer are a highly underserved population as there is no active approved therapy available at this time. Targeted therapeutics, such as dual inhibitors of RET and VEGFR2, are the first compounds showing activity in this disease. The phase 1 results of XL184, the first such molecule in this class also to inhibit the oncogenic MET receptor, were reported... (PR Newswire)

    A Man with Metastatic Renal-Cell Carcinoma  May 29, 2008
    NEJM -- Case 17-2008 -- A 63-Year-Old Man with Metastatic Renal-Cell Carcinoma. Volume 358:2389-2396. (New England Journal of Medicine)

    MRIN to focus on liver cancer research  May 28, 2008
    It is aimed at developing innovative immunotherapy intervention strategies for the treatment of cancer. The last division, Genomic, would support the other divisions by isolating defined DNA sequences, obtaining multiple copies of it in vitro, so that the sequence may be expressed in a particular host system. (Jakarta Post, Indonesia -- Features)

    Allergies gotcha? Here's help  May 28, 2008
    What it is: Allergy shots How it works: Officially called immunotherapy; a doctor injects you with small but increasing amounts of allergen until your immune system adjusts. Benefits: Can actually cure allergies in many cases. (OregonLive, OR -- News)

    Sublingual Immunotherapy  May 22, 2008
    Volume 358:2259-2264. Anthony J. Frew, M.D.. (New England Journal of Medicine)

    First Evidence Of Native Dendritic Cells In Brain Surprises Scientists  May 21, 2008
    25, 1999) Dendritic cell immunotherapy, a process that uses a vaccine derived from a patient's own cells to fight malignant cells, is being used to treat brain tumors at Cedars-Sinai Medical Center in Los. (Dec. (Science Daily)

    First Conclusive Evidence Of Alzheimer's-like Brain Tangles In Nonhuman Primates Found  May 16, 2008
    In another study, Rosen is looking at the structure of beta-amyloid protein in multiple primate species with the hope of identifying the correct target for new drugs and immunotherapy. Rosen noted Yerkes has provided her with unparalleled access to resources for graduate-level research and training. (Science Daily)

    The vaccine that could cure hay fever forever  May 16, 2008
    JENNIFER ROMANCES IN NY. Hot new couple Jennifer Aniston and John Mayer take their romance to the Big Apple. (Daily Mail)

    Skin cancer can sneak up on you  May 13, 2008
    It was removed, and Rea began immunotherapy. Click for related content. (MSNBC -- Health)

    Allergy expert says expect cure for peanut allergy in five years  May 7, 2008
    The announcement by an American expert that within the next five years some form of immunotherapy will be available to treat peanut allergy, will bring relief to many concerned parents ... Professor Burks says future treatments are all focused around curbing the immune response or inducing the immune system to tolerate a specific food allergen, possibly by introducing engineered peanut proteins as immunotherapy, where the food is ingested in increasingly larger amounts on a regular basis ...... (News-Medical.net)

    Possible Peanut Allergy Cure on the Horizon  May 6, 2008
    Researchers at Duke University Medical Center in Durham, N.C., are hoping a form of immunotherapy that eradicates peanut allergies will be available within five years, according to an article recently published in The Lancet ... Bassett said he is gratified to know that a form of immunotherapy for peanut allergies was on the horizon because the condition can be life-threatening ... Because an immunotherapy approach is not yet available, Bassett said patients should have an emergency plan in... (Fox News)

    New immune treatment may control AIDS virus  May 3, 2008
    The treatment is called OPAL, for Overlapping Peptide-pulsed Autologous Cells, and would be categorized as an immunotherapy technique, or a so-called therapeutic vaccine, Stephen Kent of the University of Melbourne and colleagues said ... "The immunotherapy resulted in fewer deaths from AIDS. We conclude this is a promising immunotherapy technique. Trials in HIV-infected humans of OPAL therapy are planned." ... "Virus-specific CD4 T cells are typically very weak in HIV-infected humans or... (Scientific American)

    New 'OPAL Therapy' presents simple, cost-effective method of treating HIV infection  May 3, 2008
    Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens ... CITATION: De Rose R, Fernandez CS, Smith MZ, Batten CJ, Alcantara S, et al. (2008) Control of Viremia and Prevention of AIDS following Immunotherapy of SIV Infected Macaques with Peptide-Pulsed Blood. (EurekAlert!)

    Expert sees peanut allergy solution within 5 years  May 2, 2008
    WASHINGTON, May 1 (Reuters) - A form of immunotherapy that could get rid of a person's allergy to peanuts is likely within five years, even as the condition appears to grow more and more common, a U.S. expert said on Thursday ... "I think there's some type of immunotherapy that will be available in five years. And the reason I say that is that there are multiple types of studies that are ongoing now," Burks said in a telephone interview ... He said one possible approach is using engineered... (Reuters)

    Can Food Allergies Be Overcome With Scheduled Small Doses Of Allergens?  Apr 22, 2008
    Allergists treating hay fever and other allergies have long used immunotherapy, also known as allergy shots, to reduce their patients sensitivity to pollen, cat and dog dander, and dust mites ... Previous research has suggested that placing the allergenic food protein under the tongue or directly swallowing it, are safer methods of administering food immunotherapy ... Shortly after reaching the maintenance dose, participants will be tested with a larger amount of either egg or peanut to see if... (Science Daily)

    Allergy season hits hard  Apr 22, 2008
    Immunotherapy, which takes two forms, shots or under-the-tongue drops, also is available, he said ... Immunotherapy through shots offers the prospect of a cure, but it takes a couple of years of getting an injection once a month, Cooke said. (Durango Herald)

    New Technologies Offer More Accurate Means Of Diagnosis And Monitoring Cancer  Apr 21, 2008
    In the next step, the researchers will try to determine if autoantibody profiling can subclassify non-invasive and muscle invasive bladder tumors and predict clinical response to current immunotherapy and chemotherapy. Research will also continue on developing novel therapies that target the immune system or the tumor, she says. (Science Daily)

    Interleukin-12 Indicates Survival Prospects For Melanoma Patients  Apr 21, 2008
    21, 2007) The addition of immunotherapy to chemotherapy for malignant skin cancer that has spread does not improve survival rates, researchers have found, and patients have more serious side effects, such as. (Apr. (Science Daily)

    Immunotherapy: Enlisting The Immune System To Fight Cancer  Apr 19, 2008
    Dendritic and T cell functions in patients with metastatic hormone-refractory prostate cancer treated with GVAX immunotherapy for prostate cancer and ipilumumab ... In a phase I trial, they observed that a combination of GVAX immunotherapy with ipilimumab lowered prostate-specific antigen (PSA) levels in some patients ... D., a researcher in the Department of Pathology and Division of Immunotherapy at the Vrije Universiteit Medical Center in the Netherlands. (Science Daily)

    First Successful Libraries Of Avian Flu Virus Antibodies Created  Apr 18, 2008
    Monoclonal antibody therapy is known as passive immunotherapy because patients are treated with antibodies that were made outside of their own immune systems instead of those actively made internally. The potential for passive immunization against influenza has been evident since the Spanish influenza pandemic nearly a century ago, where the benefits of transfused blood reduced the risk of mortality by more than 50 percent. (Science Daily)

    Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease  Apr 16, 2008
    Previous clinical studies suggest that antibody-based immunotherapy may boost the body's own immune response to reduce beta-amyloid, the protein responsible for plaque formation commonly found in the brains of Alzheimer's disease patients. In addition, recent laboratory research suggests that specific forms of beta-amyloid - oligomers and fibrils that are aggregates or clusters of beta-amyloid - may be toxic to the neurological system and lead to the progression of Alzheimer's disease. (PR Newswire)

    Achoo! Worst Cities for Allergy Sufferers  Apr 16, 2008
    In those cases, working with an allergist to get proper treatment, like allergy medications or immunotherapy, is vital. The following are the Top 10 most allergy ridden cities to live in from the AAFA's annual list. (ABC News)

    Five Years Later, Patient On Vaccine Trial Still Free Of Ovarian Cancer  Apr 8, 2008
    Then she learned about a Phase I clinical research study of an ovarian cancer vaccine developed by Kunle Odunsi, MD, PhD, Surgeon in Gynecologic Oncology and Co-Leader of the Tumor Immunology and Immunotherapy Program at Roswell Park. The vaccine is designed to trigger an immune response in the significant number of women who have tumors that test positive for the antigen NY-ESO-1. (Science Daily)

    Stallin' pollen and haltin' hista-mean  Apr 2, 2008
    In some cases the use of longer-lasting "allergy shots," known as immunotherapy, might be recommended by a doctor to relieve chronic suffering, Borish added ... "Immunotherapy is generally reserved for people with the commitment, either because nasal steroids haven't worked or they'd rather do three to five years of shots rather than a lifetime of nasal steroids.". (The Cavalier Daily, VA)

    More of this story  Apr 2, 2008
    Listening to cancer specialists, the locals heard many unfamiliar terms like microarray, immunotherapy vaccines, molecular markers, and functional geonomics. Through PowerPoint displays, handouts, and speeches, the terms were mixed with phenomenal statistics, which make sense and reason only to those who deal with them daily. (Bartow Polk County Democrat, FL)

    Don't let allergies control your life  Mar 19, 2008
    Instead of going to the doctor's office to receive trigger-specific injections called immunotherapy, a patient takes home vials containing a glycerin-based serum of allergens and places several drops under his or her tongue daily for three to five years ... Sublingual immunotherapy has been used in Europe for about 15 years, but the Food and Drug Administration has not yet approved any SLIT drugs for use for seasonal allergies, according to an FDA representative. (Atlanta Journal Constitution)

    New Target For Cancer Therapy May Improve Treatment For Solid Tumors  Mar 6, 2008
    These genetically stable surrounding cells retain the molecules that present tumor antigens, which makes them a good target for immunotherapy, and they often play an enabling role in tumor growth ... By unraveling its strategies, we can enhance its effects on tumor cells and so improve the clinical prospects of cancer immunotherapy. (Science Daily)

    Under-Tongue Grass Immunotherapy Fights Hay Fever  Mar 6, 2008
    Immunotherapy, in which a person is given increasing amounts of the substance they are allergic to, followed by maintenance doses for several years, is effective for many allergies and can even produce remission, they further point out. Dahl and his team are testing immunotherapy for grass pollen allergy that comes in tablet form and is dissolved under the tongue ... While the change from 2005 to 2006 in patients on the active drug was not statistically significant, their descriptions of their... (MEDLINEplus)

    Oral Allergy Immunotherapy Helps Control Asthma  Mar 6, 2008
    TUESDAY, March 4 (HealthDay News) -- Oral allergy immunotherapy -- in the form of drops or tablets -- is effective at reducing asthma symptoms and the need for asthma medications in children who have what's known as allergic asthma, a new study finds ... "[Oral] immunotherapy is effective and safe, easy to administer, well-accepted by patients," said the study's senior author, Dr. Giorgio Walter Canonica, professor of allergy and respiratory disease at the Medical University of Genoa, Italy ...... (MEDLINEplus)

    Archives: Immunotherapy

    Back to Health News

[ Terms Of Use | Privacy | About ]
©1998-2008 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2008